Use the basic search or click on advanced for more search options.

Advanced Search Basic Search Advanced Search



Select publication to see the relevant sections.

Publication Date

    E.g., 2018-09-19
    E.g., 2018-09-19

Archive Search

1 results
12:00 AM, Sep 26, 2000  |  BC Extra | Clinical News

Genzyme Molecular Oncology begins Phase I/II trial

been surgically resected. The vaccine employs an adenovirus vector to deliver melanoma tumor antigens, MelanA/ MART1